US National Institutes of Health Awards Phase II SBIR Grant to Celsense for Immunotherapy Clinical Trial Using Novel MRI Agent
US National Institutes of Health Awards Phase II SBIR Grant to Celsense for Immunotherapy Clinical Trial Using Novel MRI Agent
read morePress Release – The US National Institutes of Health Awards Grant to Celsense, Inc. to Fund Novel Product Development
The US National Institutes of Health Awards Grant to Celsense, Inc. to Fund Novel Product Development
Press Release – Study advancing the use of 19F tracer agent in clinical immuno-oncology applications is published in Contrast Media & Molecular Imaging
Study advancing the use of 19F tracer agent in clinical immuno-oncology applications is published in Contrast Media & Molecular Imaging
Press Release – The US National Cancer Institute Awards 5-year Grant to Fund Clinical Trial Using Cell Sense Technology in Patients with Head and Neck Cancers
US National Cancer Institute Awards 5-year Grant
Continue Exploring
Products
Papers
Real-Time Results,<br />Faster and More Accurate
Celsense offers products that enable real-time MRI detection of inflammation and cellular therapeutics. The mission of the company is to be the standard for cellular imaging in human health.
GET IN TOUCH
Send Us A Message
© 2020 Celsense, Inc. All rights reserved.